Leukemia 2021 Apr 28
Are polycythemia vera, essential thrombocytosis, and primary myelofibrosis 1, 2, or 3 diseases?   

Related Questions

Concordant low EPO level and bone marrow with megakaryocyte hyperplasia

No evidence of palpable splenomegaly, normal hematocrit and platelet count

Ropeginterferon is now a preferred therapy for Polycythemia Vera (PV) as per a recent update to the NCCN guidelines.